novartis malaria - Search News

News

1st Malaria Drug Approved for Newborns and Small Babies

Reuters on MSN · 5d

Novartis wins approval for first malaria drug for newborns and babies

Novartis said on Tuesday it had received approval in Switzerland for Coartem Baby, which it said was the first drug to treat malaria in babies and very young children. Eight African countries who participated in the assessment are now expected to issue quick approvals for the treatment,

Novartis receives approval for first malaria medicine for newborn babies and young infants

Coartem® (artemether-lumefantrine) Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight African countries now expected under a special global health scheme run by Swiss agency for therapeutic products (Swissmedic)

CNN on MSN · 4d

First malaria drug for newborns and young infants expected to be approved in Africa within weeks

The approval of the first malaria treatment for newborns and young infants could lead to imminent widespread use in Africa, drugmaker Novartis said Tuesday.

6h

Why Novartis Is Still A 'Buy' After 15% Surge

Novartis shares climb on strong Cosentyx sales, franchise growth, and a new malaria drug approval despite political risks.

Pharmalittle: We’re reading about Medicare drug negotiations, a Novartis malaria drug, and more

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results